Literature DB >> 15330895

Malpractice risks associated with colon cancer and inflammatory bowel disease.

Andrew D Feld1.   

Abstract

Analyses of lawsuits against gastroenterologists suggest that the disorders of colon cancer and inflammatory bowel disease are among the more common disorders resulting in malpractice claims, with colon cancer suits receiving some of the highest monetary judgments. Unfortunately, that composite data does not specify the exact alleged wrongdoing, but uses global categories such as "errors of diagnosis." This review will focus on potential legal pitfalls regarding those disorders. The focus is on the legal theories, not the exact medical approach recommended, and is intended as general education, and not legal advice for any specific patient.

Entities:  

Mesh:

Year:  2004        PMID: 15330895     DOI: 10.1111/j.1572-0241.2004.40943.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  Defensive medicine practices among gastroenterologists in Japan.

Authors:  Toru Hiyama; Masaharu Yoshihara; Shinji Tanaka; Yuji Urabe; Yoshihiko Ikegami; Tatsuma Fukuhara; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  Medical malpractice litigation related to gastrointestinal endoscopy in Japan: a two-decade review of civil court cases.

Authors:  Toru Hiyama; Shinji Tanaka; Masaharu Yoshihara; Tatsuma Fukuhara; Shinichi Mukai; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

3.  Medical professional liability risk and mitigation: an overview for early-career gastroenterologists.

Authors:  John Azizian; Camellia Dalai; Megan A Adams; James H Tabibian
Journal:  New Gastroenterol       Date:  2021-03-08

4.  Disparities in evaluation of patients with rectal bleeding 40 years and older.

Authors:  Helen M Shields; Elena M Stoffel; Daniel C Chung; Thomas D Sequist; Justin W Li; Stephen R Pelletier; Justin Spencer; Jean M Silk; Bonita L Austin; Susan Diguette; Jean E Furbish; Ruth Lederman; Saul N Weingart
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

5.  The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer.

Authors:  Thomas E Adrian; Rene Hennig; Helmut Friess; Xianzhong Ding
Journal:  PPAR Res       Date:  2009-01-27       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.